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Abstract. As a response to invading microorganisms, the
innate immune system of arthropods has evolved a com-
plex arrangement of constitutive and inducible antimicro-
bial peptides that immediately destroy a large variety of
pathogens. At the same time, venomous arthropods have
developed an additional offensive system in their venom
glands to subdue their prey items. In this complex venom
system, several enzymes, low-molecular-mass com-
pounds, neurotoxins, antimicrobial and cytolytic peptides
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interact together, resulting in extremely rapid immobi-
lization and/or killing of prey or aggressors. This review
provides an overview of antimicrobial peptides identified
in the hemolymph of venomous arthropods, and espe-
cially of cytolytic peptides in their venom. For these pep-
tides a dual role is proposed: acting as antimicrobials as
well as increasing the potency of the venom by influenc-
ing excitable cells.
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Introduction
As strategies in antagonistic relationships, prokaryotic
and eukaryotic organisms have developed hundreds of
different cytolytic peptides and proteins during their evo-
lution in different phyla of the plant [1] and animal king-
dom [2]. Many cytolytic peptides are specific antimicro-
bially acting peptides that are part of the innate immune
system of invertebrates and vertebrates. They serve as
primary defense weapons against invading prokaryotic
and eukaryotic microorganisms, a fact which is well doc-
umented by a constantly increasing number of publica-
tions and reviews [3–6].
Gene-encoded antimicrobially acting peptides show great
variety in amino acid sequence, structure and target
specificity. Many of them are cationic, amphipathic pep-
tides with molecular masses lower than 10 kDa and show
a higher specificity to prokaryotic than to eukaryotic cells
[7]. The main site of antimicrobial activity is the plasma
* Corresponding author.
membrane of bacteria and parasitic protozoans. The un-
structured antimicrobial peptides are electrically at-
tracted to negatively charged groups of the cell surface,
where they adopt an a-helical conformation and accumu-
late on the membrane. This can result in the formation of
transient pores, membrane perturbation and cell lysis [8].
Antimicrobial peptides in vertebrates and invertebrates
can either be induced by microbial infection and inflam-
mation or produced constitutively. In vertebrates, biogen-
esis occurs in circulating phagocytes, destroying intracel-
lularly phagocytosed pathogens by defensins and like-
wise in different tissues and epithelia from where they are
actively secreted into the lumen, as has been shown for
enteric a-defensins [9]. In some crustaceans [10, 11] and
chelicerates, these peptides are stored constitutively in
hemocytes and released into the hemolymph by exocyto-
sis after microbial injury as an ancient form of host de-
fense [12, 13]. Insects exhibit a further mode of action in
response to microbial challenge. Depending on the im-
munogenic character of the microbial invaders, the tran-
scription of different antimicrobial peptides, mainly in
the fat body, is induced by two different pathways. The
Imd pathway controls the immune response to Gram-neg-
ative bacteria, and the Toll pathway is activated after in-
fection with fungi and Gram-positive bacteria [5]. After
induction, a rapid release of diverse antimicrobial pep-
tides into the hemolymph follows within hours [14]. Fur-
ther constitutive expressions of these peptides are also re-
ported in hemocytes, salivary glands [15] and in the
midgut of Anopheles gambiae [16, 17].
Additionally, other cytolytic peptides are used facilita-
tively for the improvement of living conditions and access
to nutrition. Bacteria that produce cytolytic peptides
seem to have a growth advantage over their natural com-
petitors for the same growth substrate and in the same
ecological niche [18, 19]. This bactericidal activity can be
specifically targeted at bacteria of the same group [20] or
may occur as a more unspecific cytolytic activity against
prokaryotic and eukaryotic cell membranes, as in the case
of gramicidin S [21]. Cytolytic peptides from the para-
sitic protozoans Entamoeba histolytica and Entamoeba
dispar (amoebapores and disparpores) primarily destroy
the phagocytosed bacteria as food. The cytolytic activity
toward eukaryotic cells that some of them exert seems to
be a mere side effect [22, 23].
On the other hand, arthropods such as scorpions, spiders
and stinging hymenopterans have developed venom
glands that mainly produce three different groups of com-
ponents, based on their molecular mass. The first group
consists of proteins, including several enzymes such as
hyaluronidases, phospholipases and sphingomyelinases.
The second group is represented by a peptide fraction
with molecular masses around and lower than 10 kDa,
containing several neurotoxic and cytolytic compounds.
A third group is composed of low-molecular-mass sub-
stances such as ions, free amino acids, biogenic amines,
neurotransmitters, acylpolyamines, heterocyclic com-
pounds and alkaloids [24, 25]. The cooperation of all
these mentioned components in the venom enables these
arthropods to paralyze and/or to kill other arthropods in
terms of foraging and defense. As a reproduction strategy,
parasitic wasps also paralyze other arthropods and lay an
egg inside or outside of the prey, which serves as a nutri-
tion source for their offspring. This review will focus on
antimicrobial and cytolytic peptides from the hemolymph
and venom glands of poisonous arthropods identified
over the last 40 years. Common to all peptides is their am-
phipathic structure and their ability to disturb membrane
structures. In context with the fact that all external world-
facing epithelia, ducts and glands dispose of growth-in-
hibiting substances against potential invaders, a possible
dual role, especially for the peptides identified in the
venom, will be discussed.
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Antimicrobial peptides in the hemolymph of
venomous arthropods
Antimicrobial peptides isolated from the hemolymph of
actively venomous arthropods have quite different struc-
tures from the cytolytic peptides identified in their ven-
oms. According to their structure, antimicrobial peptides
can be arranged into four families: a-helical, linear pep-
tides devoid of cysteines, the proline-rich and glycine-
rich peptides, and the cysteine-rich, open-ended cyclic
peptides such as insect defensins [14]. 
In the hemolymph of the scorpion Leiurus quinquestria-
tus (Buthidae) [26] a 4-kDa scorpion defensin was iden-
tified with a high sequence homology to an insect de-
fensin from the dragonfly Aeschna cyanea [27]. The scor-
pion defensin is a cationic 39-residue peptide with a
CSab fold and three intramolecular disulfide bridges, a
common structural motif also present in scorpion toxins
[28]. A further defensin from the hemolymph of the scor-
pion Androctonus australis, also belonging to the family
Buthidae, showed 95% identity with the Leiurus de-
fensin, both acting mainly on Gram-positive bacteria
[29]. These high sequence similarities suggest a common
ancient peptide structure for scorpion neurotoxins and in-
sect defensins [30]. From the same hemolymph, two fur-
ther antimicrobially acting peptides were characterized:
buthinin, with three disulfide bridges, active against both
Gram-positive and Gram-negative bacteria, and androc-
tonin, with two disulfide bridges. Androctonin is bacteri-
cidal in the micromolar range to both Gram-positive and
Gram-negative bacteria. The peptide additionally exhibits
a fungicidal activity and is nonhemolytic up to a concen-
tration of 150 mM [31]. Its sequence shows a close simi-
larity to antimicrobial tachyplesins and polyphemusins
isolated from the hemolymph of the horseshoe crabs
Tachypleus tridentatus and Limulus polyphemus, belong-
ing to the old marine arthropod group Xiphosura [32, 33].
As assumed for cytolytic peptides from the venom of
scorpions, antimicrobial peptides in the hemolymph also
seem to be constitutively present, because their concen-
tration does not increase after bacterial injury [26, 29].
Antimicrobial peptides from the hemolymph of spiders
are currently known from one unchallenged mygalo-
morph species, Acanthoscurria gomesiana (Theraphosi-
dae), from which gomesin had been characterized [34].
This peptide contains four cysteines and is active against
different Gram-negative bacteria (0.4–6.25 mM), Gram-
positive bacteria (0.2–12.5 mM) and fungi (0.4–25 mM).
Gomesin exhibits hemolytic activity of 16% at 1 mM,
which does not increase up to concentrations of 100 mM.
Interestingly, the viability of Leishmania amazonensis
promastigotes was reduced to 50% in the presence of 
2.5 mM gomesin. Structural and sequence alignment of
gomesin with protegrin from porcine leukocytes [35] and
androctonin revealed several similarities in their amino
acid sequences as well in the structural distribution of hy-
drophilic and hydrophobic residues [36, 37].
Among stinging hymenopteran insects, antimicrobial
peptides are best investigated from the hemolymph of the
honeybee Apis mellifera, as a recent review reports [38].
After bacterial injury, the proline-rich 18-residue api-
daecins, the 34-residue abaecins and the glycine-rich hy-
menoptaecin with 93 residues are present in micromolar
concentration in the hemolymph [39–41]. All three pep-
tide groups are devoid of cysteine. Apidaecins are active
against Gram-negative bacteria and lack a pore-forming
activity. This peptide group shows a stereospecific inter-
action with bacterial targets and a direct effect on protein
biosyntheses [42]. Apidaecins are also present in the he-
molymph of the bumblebees Bombus terrestris and Bom-
bus pascuorum, as well as in the wasps Vespula macu-
lifrons and Vespula maculata. They exhibit a conserved
C-terminal part that seems to be specific for hymenopter-
ans [43, 44]. Abaecin is, like hymenoptaecin, active
against both Gram-positive and Gram-negative bacteria,
but compared with apidaecins it is less bactericidal. This
peptide has also been identified in the hemolymph of
Bombus pascuorum. Apis defensin is less common in the
hemolymph even after bacterial challenge [45] and dif-
fers from royalisin, isolated from honeybee royal jelly,
only in one C-terminal amino acid residue and a C-termi-
nal amidation [38, 46]. Bombus defensin from the he-
molymph of Bombus pascuorum also possesses an ami-
dated C-terminus and features similarities to Apis de-
fensin and royalisin. In contrast to other insect defensins
and royalisin, it is active against Gram-positive and
Gram-negative bacteria [44]. The hymenopteran de-
fensins identified consist of 51 residues, contain the char-
acteristic motif of three intramolecular disulfide bridges
and are larger than other insect defensins. 
Sequence similarities to royalisin and defensin from Apis
mellifera and Bombus pascuorum have been found in a
40-residue defensin from the European ant Formica rufa,
also belonging to the Hymenoptera. This defensin also
contains three intramolecular disulfide bridges without
any further additional modifications [44, 46, 47]. The for-
maecins 1 and 2, from the hemolymph of the Australian
ant Myrmecia gulosa have also been characterized as be-
longing to the proline-rich peptide family [48]. These
small cationic, O-glycosylated antimicrobial peptides (2
kDa) are active against growing Escherichia coli and in-
active against Gram-positive and several other stationary
cells. The O-glycosylation of Thr11 seems to be impor-
tant for its activity. An overview of these antimicrobial
peptides in the hemolymph of venomous arthropods is
given in Table 1.
Antimicrobial and cytolytic peptides in the venom
of arthropods
Besides the previously mentioned antimicrobial peptides
from their hemolymph, scorpions, spiders and stinging
hymenopterans have, during their evolution, also devel-
oped antimicrobial, cytolytic peptides in their venom
glands together with a complex mixture of enzymes, neu-
rotoxins and low-molecular-mass compounds. Despite
their different compositions, these venoms have two main
purposes: first, they are used to subdue mainly arthro-
pods as food. Second, they serve as a defense weapon
against invertebrate and vertebrate predators. The venom,
which is injected, has the job of immobilizing and/or
killing prey or enemies as soon as possible. The better and
more effective the different venom components work to-
gether, the less venom has to be injected. Venom is prin-
cipally precious because it takes Cupiennius salei several
days to regenerate, and a venomless period is a defense-
less time [49]. As shown for the spider Cupiennius salei
and the scorpion Parabuthus transvaalicus, venom in-
vestment is allotted as economically as possible [50–54].
Generally, neurotoxins identified in various arthropod
venoms modify ion conductance (ion channel toxins), af-
fect neurotransmitter release (presynaptic toxins) and in-
terfere with the binding of neurotransmitters (postsynap-
tic toxins) [55]. For example, diverse voltage-gated
sodium channels in muscle cells and the central and pe-
ripheral nervous system of insects and mammalians are
targets of a and b toxins (scorpions) and m-agatoxins (spi-
ders), leading to fast excitatory paralysis [56–58]. In ad-
dition, many neurotoxins act on voltage-gated calcium
channels, which play an important role in cardiac, muscu-
lar and neuronal function, resulting in a flaccid paralysis
[58]. So the diverse predators have developed different
strategies to paralyze a prey and to deter aggressors.
Before discussing the role of antimicrobial peptides in the
context of the other venom compounds, a detailed
overview of the peptides so far characterized is given. The
majority of the cytolytic peptides identified so far in the
venom of arthropods are linear, highly cationic and am-
phipathic peptides without cysteine residues and have
isoelectric points above pH 8.57. They adopt an a-helical
structure in the presence of membranes and membrane
mimicking substances such as trifluoroethanol. Also, a
defensin-like peptide, scorpine [59], which contains three
disulfide bridges, was isolated.
Scorpions
First reports on the hemolytic activity of scorpion venom
have been available since 1918 [60]. Starting in 1996,
possible pore-forming peptides from the venom of Scor-
pio maurus palmatus and Opistophthalmus carinatus
CMLS, Cell. Mol. Life Sci. Vol. 60, 2003 Review Article 2653
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(both Scorpionidae) were assumed to be responsible for
the induction of leak currents in Xenopus laevis oocytes
[61] and cardiac cells of the rat [62]. 
Meanwhile, cytolytic peptides have been identified in the
venoms of three out of four scorpion superfamilies. Puri-
fied and characterized cytolytic peptides have been de-
scribed for Parabuthus schlechteri (Buthidae) [63, 64],
Pandinus imperator [59, 65] and Opistophthalmus cari-
natus (Scorpionidae) [64], Opisthacanthus madagas-
cariensis (Ischnuridae) [66] and Hadrurus aztecus (Iuri-
dae) [67]. From the venom gland of the Chinese scorpion
Buthus martensii (Buthidae) a full-length cDNA was iso-
lated that encodes an insect defensin-like peptide named
BmTXKS2 [68]. BmTXKS2 shows a similar CSab struc-
tural motif and high sequence homology with Leiurus and
Androctonus defensins from the hemolymph of these
scorpions also belonging to the Buthidae family [26, 29].
The pore-forming peptide parabutoporin from the South
African scorpion Parabuthus schlechteri shows a high
content (26.6%) of basic amino acid residues, mainly ly-
sine, which is remarkable. Additionally, five negatively
charge amino acid residues are located in the C-terminal
part of the peptide (table 2). At submicromolar concen-
trations the peptide causes degranulation of human gran-
ulocytes, which is comparable to the effect of masto-
paran, a pore-forming peptide from wasp venom. The
peptide-containing fraction was also able to depolarize
nociceptive nerve cells of dorsal rat ganglions [63].
Opistoporin 1 and 2, from the South African scorpion
Opistophthalmus carinatus, have also been purified. The
peptides differ from each other only in one position (table
2, 3). Synthesized parabutoporin and opistoporin 1 were
most bactericidal to different Gram-negative bacteria
(1.6–50 mM), less so to Gram-positive bacteria (6.3 to 
≥ 50 mM), and fungicidal to different fungi and one yeast
species in micromolar concentrations. Opistoporin 1 is
less hemolytic than melittin and parabutoporin in the mi-
cromolar range. CD spectra of parabutoporin and opisto-
porin 1, in the presence of negatively charged (Myr2Gro-
PGro) and zwitterionic (Myr2Gro-PCho) small unilamel-
lar vesicles, showed no great differences in secondary
structure. The peptides show synergistic effects with
some conventional antibiotics. When an N- and C-termi-
nal truncated form of parabutoporin (amino residues
7–22) and a C-terminal truncated form of parabutoporin
(amino acid residues 1–28) were tested, almost no bio-
logical effect could be found at a concentration of 50 mM.
Comparison of primary structures of further cytolytic
peptides described for different scorpion venom peptides
by CLUSTAL W sequence alignment revealed a typical
scorpion conserved sequence: S(x)3KxWxS(x)5L [64].
Currently, one of the longest described antimicrobial pep-
tides from the venom glands of arthropods is scorpine
from the West and Central African scorpion Pandinus im-
perator, with 75 amino acid residues (table 3) [59]. The
secondary structure prediction of scorpine [69] shows an
a-helical conformation for the N-terminal residues 5–16
and 18–46, which exhibits similarities to cecropin B
(from the Chinese oak silk moth, Antheraea pernyi) [70],
sarcotoxin Ic (from the flesh fly, Sarcophaga peregrina)
[71] and cecropin P1 (from the pig intestine, Sus scrofa)
[72]. Scorpine possesses three disulfide bridges in the C-
terminal region that bear resemblance to the defensins
from the dragon fly Aeschna cyanea [27] and from the
scorpion Leiurus quinquestriatus hebraeus [26]. Depend-
ing on the purification procedure, scorpine corresponds
to approximately 1.4% of the total venom. Scorpine in-
hibits bacterial growth of Bacillus subtilis and Klebsiella
pneumoniae in the micromolar range and also the fecun-
dation and ookinete formation of the eukaryotic parasite
Plasmodium berghi, the organism causing malaria.
Pandinin 1 and 2, further cationic antimicrobial peptides
from P. imperator, have demonstrated antimicrobial ac-
tivity in the micromolar range against various Gram-posi-
tive bacteria (2.4–5.2 mM) and Gram-negative bacteria
(2.4–38.2 mM). Pandinin 2 also exhibits fungicidal (Can-
dida albicans) and hemolytic activity (11.1–44.5 mM)
stronger than magainin 1 against sheep erythrocytes. C-
terminal amidation of synthetic pandinin 2 has no effect
on the antimicrobial and hemolytic activity of the pep-
tide. Both peptides seem to be present only in small
amounts in the venom of P. imperator. The N-terminal
part of pandinin 2 is predominated by hydrophobic amino
acid residues comparable to melittin, magainin and cupi-
ennin 1 and is composed of a single a-helix. Pandinin 1
shows two distinct a-helices that are separated by a coil
region of higher flexibility. One-dimensional 1H NMR
spectra of pandinin 2 in dodecylphosphocholine (DPC)
micelles suggest that the N-terminal part is more deeply
buried in the lipid phase than the C-terminal region [65].
A further cationic antimicrobial peptide has been purified
from the venom of the Mexican scorpion Hadrurus
aztecus [67] (table 2, 3). When the antimicrobial activity
of native hadrurin against E. coli was compared with that
of synthesized all-L-hadrurin in the free or amidated C-
terminal form and all-D-hadrurin (with the exchange of
Leu in position 2, 6, 9 and 27 with Ile), no clear differ-
ences could be observed. A difference in the hemolytic
effect against human erythrocytes was only measured for
the all-D-enantiomer, which is in the same range as the
effect of melittin (100% hemolysis at a concentration of
5 mM). The hemolytic effect of the other forms of
hadrurin mentioned are reduced to 80% lysis at a con-
centration of 20 mM. Hadrurin preferentially lyses zwit-
terionic phosphatidylcholine liposomes at a low concen-
tration. For the lysis of acidic liposomes (composed of
phophatidyl-choline and phosphatidyl-serine), a higher
critical molar ratio peptide/lipid is required.
Opisthacanthus madagascariensis, a scorpion endemic
to Madagascar, is the source of the shortest cytolytic pep-
CMLS, Cell. Mol. Life Sci. Vol. 60, 2003 Review Article 2655
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tides, IsCT [73] and IsCT2 [66], from scorpion venom.
They are composed of 13 amino acid residues with an
amidated C-terminus and differ from each other in only 3
amino acid residues (table 2, 3). Both peptides are bacte-
ricidal against Gram-negative bacteria (3.3 to ≥ 150 mM),
more effective against Gram-positive bacteria (0.7–17.1
mM), and show hemolysis of sheep erythrocytes of about
20% (IsCT2) and 30% (IsCT) in a concentration of 200
mM. IsCT releases histamine from rat peritoneal mast
cells to a higher degree than mastoparan in a comparable
concentration. The lytic ability of IsCT and IsCT2 is in a
relatively low peptide-to-lipid ratio higher for phospha-
tidic acid than for phosphatidylcholine containing uni-
lamellar vesicles. From the venom, two C-terminal trun-
cated forms of both peptides, which lack the last two
amino acid residues, were isolated. These nonamidated
forms showed neither bactericidal nor hemolytic activity
and were shown to be the result of proteolytic activity of
the scorpion venom [66]. Analyses of the cDNA encod-
ing the precursors of IsCT and IsTC2 revealed that, be-
sides the signal peptide of 23 amino acid residues, both
contained an unusual acidic propeptide (3 Glu/7 Asp) at
the C-terminal with unknown function. This precursor
structure is similar to the precursors of tachyplesins iso-
lated from the hemocytes of horseshoe crabs [74], which
are cysteine-rich antimicrobial peptides composed of 17
amino acid residues. However, the precursor of neurotox-
ins [75, 76] and the antimicrobially acting scorpine from
scorpion venom [59] show a different structure.
Spiders
So far, cytolytic peptides from the venom of spiders have
only been described for labidognath spiders, especially
from members of the superfamily Lycosidoidea (wolf-
spider-like spiders), which are mainly non-web-building,
omnivorous hunting spiders. These investigations con-
cern two species from the genera Hogna and Lycosa (wolf
spiders, Lycosidae), one Oxyopes species (lynx spiders,
Oxyopidae) and Cupiennius salei (ctenids, Ctenidae).
Cytotoxic effects on cultured cell lines of venoms from
Araneidae (Neoscona arabesca, Eriophora edax), Ly-
cosidae (Lycosa helluo, Lycosa sp., Trochosa sp.), Oxy-
opidae (Peucetia viridans, Oxyopes sp.), Salticidae
(Phidippus ardens, P. johnsoni, P. octopunctatus),
Theridiidae (Latrodectus hesperus) and the orthognath
spider Aphonopelma sp. give evidence for further possi-
ble sources of cytolytic peptides [77].
The first description of antimicrobial activity was pub-
lished in 1989 for Lycosa singoriensis from China, a
species widespread in the palearctic. The purified peptide
was active against E. coli and composed of 43 to 45
amino acid residues, one-fourth of them basic and one-
third hydrophobic amino acid residues [78]. From Hogna
carolinensis (mentioned as Lycosa carolinensis), a
species widely distributed in Mexico and in the United
States, the antimicrobial peptides lycotoxin I and II were
purified. They occur in the crude venom at a concentra-
tion of 1–5 mM. These cationic peptides are character-
ized by lysine repeats occurring at every fourth or fifth
position. Lycotoxins inhibit the growth of Gram-negative
and, to a higher degree, Gram-positive bacteria at micro-
molar concentrations. Beside fungicidal (against Can-
dida glabrata) and hemolytic activity in higher concen-
trations, they are able to dissipate voltage gradients
across insect muscle membranes. These cytolytic pep-
tides seem to interfere with the ability of rat synapto-
somes to sequester Ca2+, and lycotoxin I dissipates ion
gradients of synaptosomes preloaded with 45Ca2+. When
applied together, the lycotoxins show mainly an additive
antimicrobial effect, assuming only little or no synergis-
tic action [79].
Oxyopinins are large amphipathic peptides with a non-
amidated C-terminus isolated from the lynx spider Oxy-
opes takobius (erroneously identified as Oxyopes
kitabensis) [80]. They can be divided into two peptide
groups: oxyopinin 1 includes a Pro at position 24, indi-
cating a possible flexible hinge region that could separate
two segments of a-helices in the peptide. Oxyopinins 2a,
b, c and d exhibit highly similar sequences and 27 con-
served amino acid residues. Both peptide groups are
characterized by a 6- to 9-fold repeat of 3 to 4 amino acid
residues, always starting with lysine or arginine (table 2,
3). Similar to oxyopinin 1, a possible flexible hinge re-
gion is given by Gly19-Val20-Gly21. No data are available
about their concentrations in the crude venom, but the re-
lative concentrations of the pure peptides oxyopinin 1 and
oxyopinin 2 are about 4.6 times higher than the concen-
tration of the isolated neurotoxin OxyTx1. Synthetic oxy-
opinin 1 shows strong antimicrobial activity toward both
Gram-negative and Gram-positive bacteria at micromolar
concentrations. Synthetic oxyopinin 2b is more lytic to
Staphylococcus aureus than to E. coli. The hemolytic ef-
fect of the oxyopinins on various mammal erythrocytes
seems to differ in dependence on the content of phos-
phatidylcholine in the different erythrocytes. Oxyopinin
1, and to a lesser degree oxyopinin 2b, is able to bind to
different phospholipid bilayers. The leakage of their con-
tent, probably mediated by the oxyopinins, is strong for
bilayers containing phospatidylcholine, followed by
phosphatidylethanolamine and phosphatidic acid. Up to a
peptide concentration of 200 mM, no cytolytic effect on
negatively charged hemocytes of the cutworm
Spodoptera litura could be observed. Both oxyopinin
groups produce a drastic reduction of Spodoptera
frugiperda pupal ovary cell (Sf9) membrane resistance by
opening nonselective ion channels, as shown by electro-
physiological recordings. Injection of oxyopinin 1 and 2b
into S. litura larvae resulted in necrotic spots at the site of
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the needle insertion after 60–90 min postinjection. Coin-
jection of the neurotoxin OxyTx1 and of oxyopinin 1 in a
molar ratio of 1:5 into S. litura larvae showed significant
lower LD50 values than the LD50 values of the neurotoxin
alone. This cooperative lethality effect of the peptide
mixture leads to an enhancement of the paralytic and
lethal activity in a dose- and time-dependent manner.
The neotropical spider Cupiennius salei, which lives in
Central America, also has cytolytic peptides in its venom,
and a first peptide family was named cupiennin 1 [81,
82]. Cupiennin 1a, b, c and d are characterized by a high
total charge of +8 because of lysine residues (table 2, 3).
These cupiennins have an amidated C-terminus. The
amino acid sequences are highly conserved; only in the
hydrophobic N-terminal part and in the more hydrophilic
C-terminal part are 5 out of 35 amino acid residues ex-
changed. The central part of the cupiennins consists of a
6-fold repeat of 4 amino acids, with lysine at every first
position. The amphipathic motif is characterized by a
right-handed ribbon of positively charged side groups of
lysine and polar amino acids winding around the a-helix
of the cupiennins. Cupiennin 1a occurs in a concentration
of 1.2 mM in crude venom, whereas the concentrations of
cupiennin 1b, 1c and 1d are ten times lower. Cupiennin
1a, 1d, the synthetic cupiennin 1a* (with Glu as a non-
amidated C-terminal amino acid) and the synthetic cupi-
ennin 1d* (with Gln as a nonamidated C-terminal amino
acid) are active against Gram-negative and Gram-positive
bacteria in the submicromolar range. The cupiennins also
show a hemolytic effect on human erythrocytes, which 
is lower than the effect of melittin by a factor of 8 to 14.
The insecticidal effect of cupiennins on Drosophila
melanogaster flies, quantified as paralysis and death, is
dose-dependent, and the LD50 values (5–8 pmol/mg fly)
are significantly higher than the LD50 value of the main
neurotoxin CSTX-1 (0.35 pmol/mg fly) but in the same
concentration range as CSTX-2a [83, 84] and CSTX-9
[85], two other neurotoxins from the venom of C. salei.
No difference in the cytolytic activity is found between
the C-terminal amidated and nonamidated forms. Injec-
tions of 0.05 ml of different cupiennins in LD50 concen-
trations into D. melanogaster were impeded by the fact
that very often the injected volumes flowed out between
the injection opening and the glass capillary. We interpret
this effect as a direct cytolytic action of cupiennins on the
tissue next to the injection capillary. This effect was only
observed for the cytolytic peptides cupiennin and melit-
tin but never during the injection of different neurotoxins
or other proteins, even in high millimolar concentrations.
Further experiments with synthetic N- and C-terminal
truncated forms of cupiennin 1d* showed that the major
determinants of structure and cytolytic activity are lo-
cated in the hydrophobic N-terminal chain segment. Re-
moval of the first six N-terminal amino acids implicated
no further biological activities of the truncated peptide. It
seems that the more-polar C-terminus modulates the pep-
tide accumulation at negatively charged cell surfaces via
electrostatic interaction [86].
Insects
Over three decades ago, direct hemolytic activities had
been observed in venoms of different bees, wasps and
ants [24]. The venoms of stinging hymenopterans contain
a variety of biologically active substances. Besides high
levels of hyaluronidase and phospholipases, neurotoxins,
kinins, hemolysins and low-molecular-mass compounds
like histamine and serotonin [25], more and more cy-
tolytically active peptides have been identified and char-
acterized. Apocritan hymenopterans are roughly divided
into parasitic wasps (such as Ichneumonidae and Bra-
conidae), spider wasps (Pompilidae), ants (Formicidae),
wasps (Vespidae and Eumenidae), and bees and bumble-
bees (Apidae).
Bees and bumblebees
Apidae use their venoms mainly for defending them-
selves and their colonies against invertebrate and verte-
brate aggressors. One of the best-investigated cytolytic
peptides from the bee family is melittin, the major com-
ponent of the honeybee Apis mellifera venom [87–89].
Hundreds of publications are available on its biological
activity, structure and membrane interactions. The reader
is referred for more information to detailed reviews
[90–93]. Briefly, melittin is characterized by a hydropho-
bic N-terminus and a helix kink induced by the GXP mo-
tif followed by a more polar amidated C-terminal part
(table 2, 3). It is a bent a-helical rod as determined from
crystals grown in aqueous solutions [94, 95]. At 40% of
the dry weight, melittin is the main component in bee
venom followed by phospholipase A2 with 10–12% [96].
The peptide causes lysis of erythrocytes from different
species and induces release of histamine from mast cells
[97], bilayer micellization, membrane fusion and voltage-
dependent ion channels across planar lipid bilayers [91,
93, 98]. Melittin interacts with many proteins such as
calmodulin [99], calsequestrin [100], myosin light chains
[101], negatively charged lipids and gangliosides [91,
102]. Its affinity for negatively charged lipids is about
100-fold greater than for zwitterionic lipids [103]. Melit-
tin facilitates the activity of phospholipase A2 [97], the
mast cell degranulating peptide P401 from honeybee
venom [96], protein kinase C and Ca/calmodulin-depen-
dent protein kinase II [104]. Inhibitory activities of melit-
tin have been described for many ion-motive ATPases
[105]. In addition to the effects just described, melittin
shows an insecticidal activity toward D. melanogaster,
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acts antimicrobially to Gram-positive and Gram-negative
bacteria and to fungi in the micromolar range, and is
nearly as active as cytolytic peptides from spider venoms
[64, 82, 106, 107].
Bombolitins, cytolytic peptides isolated from the venom
of the bumblebee Megabombus pennsylvanicus [108], are
five structurally related heptadecapeptides possessing
one to three cationic residues and an amidated C-termi-
nus (table 2, 3). They constitute about 25% of the dry
weight venom. Bombolitin II is at 33% the most abun-
dant of all bombolitins. As with other cytolytic peptides
from wasp and bee venoms, the bombolitins lyse erythro-
cytes, facilitate the activity of phospholipase A2 and
cause the release of histamine from mast cells. Bom-
bolitin V shows the same lytic activity towards erythro-
cytes as melittin and is five times more potent in releas-
ing histamine than mastoparan.
Wasps
Social and solitary wasps of the families Vespidae and
Eumenidae and the solitary spider wasps of the family
Pompilidae use their venom for prey capture and defense.
In contrast to social wasps, which feed their brood with
pulpified prey items, solitary wasps store paralyzed prey
to feed their larvae. So far, many cytolytic peptides in the
venom of social wasps have been characterized:
mastoparan from Vespula lewisii [109], mastoparan B
from Vespa basalis [110], mastoparan M from Vespa
mandarinia [111], mastoparan X from Vespa xanthoptera
[112], mastoparan C and crabrolin from Vespa crabro,
HR-I and II from Vespula orientalis [113] and Polistes
mastoparan from Polistes jadwigae [114]. The cytolytic
eumenine mastoparan from the solitary eumenine wasp
Anterhynchium flavomarginatum micado [115] and
anoplin from the solitary spider wasp Anoplius samarien-
sis [116] have been described. All these mastoparans and
HR-I are very similar, being able to adopt an amphipathic
a-helical structure and being composed of 14 residues
with two to four cationic amino acids. All hitherto char-
acterized cytolytic peptides from the venom of these
wasps possess an amidated C-terminal leucin-residue
(table 2, 3).
Mastoparans show many biological activities: low hemo-
lysis, mast-cell degranulation and release of histamine,
further facilitation of phospholipase A2 from different
sources [117] and activation of GTP-binding protein
[118]. The enzymatic activities of pig brain protein kinase
C, rat cerebral cortex Na,K-ATPase and also the prolifer-
ation of TPA-induced HL60 cells are inhibited by
mastoparan and analogues [119]. Mastoparan D and its
all-D analogue are bactericidal, but the all-D analogue
exhibits bactericidal activity that is twice as high. Inves-
tigation with scanning-beam electron microscopy of all-
D mastoparan-treated bacteria and tumor cell lines docu-
mented blastlike bleb extrusions on the surface for S. au-
reus, swelling on the end of E. coli and hollow, shrunk
and collapsed structures of tumor cells. These observa-
tions indicate a direct nonstereospecific cell-disrupting
mechanism of mastoparans [120, 121]. Minimal in-
hibitory concentrations for the observed bactericidal and
fungicidal effects of mastoparan are in the micromolar
range and slightly higher when compared with melittin
and cytolytic peptides from the scorpion O. carinatus
[64]. A synergistic hemolytic effect of mastoparan B with
the ‘lethal protein’ that possesses phospholipase A1 acti-
vity, both from the venom of the hornet Vespa basalis, is
reported [110]. 
Crabrolin is less hemolytic and less active in releasing
histamine and facilitating phospholipase A2 than
mastoparan [113, 122]. However, experiments with cra-
brolin and analogues suggested that the a-helical confor-
mation is necessary for its hemolytic activity, but is not a
prerequisite for its bactericidal activity [122]. Anoplin,
with 10 residues the shortest cytolytic peptide isolated
from wasp venom, shows a high homology to crabrolin
and HR-II. Both peptides show an a-helical structure in
the presence of trifluoroethanol as revealed by CD-spec-
troscopy [116]. Interestingly, anoplin also shows antimi-
crobial activity against Gram-positive and Gram-negative
bacteria, histamine release and very slight hemolytic ac-
tivity [116].
Ants
Stinging ants of different subfamilies such as Ponerinae,
Myrmicinae, Ecitoninae, Pseudomyrmecinae and
Myrmeciinae possess complex venom mixtures rich in
hyaluronidase, phospholipases, neurotoxins, histamine
and further low-molecular-mass compounds. Many of
them also contain hemolysins, active substances causing
damage of erythrocytes [123, 124], which have become
more and more interesting during the search for new an-
timicrobial peptides. Ants use their venoms mainly for
prey capture, as a defense strategy against invertebrate
and vertebrate predators and for communication. Over-
powered and paralyzed or killed prey items are mainly
carried into the nest whole or cut into small pieces and di-
rectly used as food for adults and/or for their larval brood.
Pachycondyla goeldi, a ponerine ant from French Guiana,
expresses three different antibacterial and insecticidal
peptide families in its venom gland, called ponericin G,
W and L families [125]. They exhibit molecular masses
of between 1.8 and 3.4 kDa, consist of 18 to 30 amino
acid residues and are present in concentrations between
0.3 and 23 mM in the venom. The ponericin G family is
composed of seven different peptides sharing high se-
quence similarities with each other and also with ce-
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cropin-like peptides. Comparisons of the ponericins
W1–6 with gaegurin 5, an antimicrobial peptide from the
frog Rana rugosa [126], and melittin show about 70% se-
quence similarity. The ponericins L1 and 2 are similar to
the dermaseptin family from the skin of the frog Phyl-
lomedusa sauvagii [127, 128]. All members of the poner-
icin families are highly active against Gram-positive and
Gram-negative bacteria, with lower MIC values com-
pared with melittin, cecropin and dermaseptin. Members
of the ponericin G and W families also show fungicidal
activity against the yeast Saccharomyces cerevisiae. The
ponericins W1–6 are most hemolytic against horse and
sheep erythrocytes, whereas the ponericin G and L fami-
lies showed no cytolytic activity in the tested concentra-
tion of 0.4–0.5 mM. Interestingly, all ponericin families
exhibited an insecticidal activity with LD50 between 73.8
and 607 mg/g cricket (Acheta domesticus), whereas only
two peptides (W3-desK and W4) showed a toxic effect on
the ants themselves.
Hemolytic activity in the venom of the Australian ant
Myrmecia pilosula was first reported in 1964 [129].
Meanwhile, pilosulin 1, a cationic cysteine-free and prob-
ably a-helical peptide of 56 residues has been identified.
It causes lysis of erythrocytes at micromolar concentra-
tions and is only four times less active than melittin. The
cytotoxic effect was also demonstrated on further eu-
karyotic cells such as peripheral mononuclear blood
cells, various white blood cells, and Eppstein-Barr-trans-
formed B-cells [130].
A further hemolytic peptide, barbatolysin, was isolated
from the venom of the red harvester ant Pogonomyrmex
barbatus, showing cytolytic activity on erythrocytes. Us-
ing gel filtration experiments, its molecular mass was de-
termined to be ca. 3.5 kDa. Interestingly, the amino acid
composition shows a high content of His, Gly and Glx
and a total absence of Lys, Arg, Ile and Leu residues
[131]. Unfortunately, no further structural data are avail-
able.
Antimicrobial peptides from the hemolymph and
venom: similarities and differences
So far, antimicrobial peptides identified in the he-
molymph of venomous arthropods can be subdivided into
the cysteine-containing peptides, the proline-rich and the
glycine-rich peptides. Most of the cationic peptides iso-
lated from their venoms, however, belong to the a-helical
linear peptides. The isolation of scorpine [59] and the
identification of BmTXKS2 [68], both belonging to the
cysteine-rich peptides, indicate the possibility of further
structurally different peptides in venom. The peptides in
both groups are characterized by a small size, a positive
charge at neutral pH with pI’s above pH 8.3 and a broad
antimicrobial activity. Some of the peptides from arthro-
pod venoms show additionally hemolytic and cytotoxic
activities in low micromolar concentrations [65, 82, 90,
108, 125], in contrast to gomesin from the hemolymph,
which is weakly hemolytic in high concentrations [34].
Synthesis of antimicrobial peptides in the hemolymph of
aculeate hymenopterans is induced upon infection with
different microbes, in contrast to scorpions, which exhibit
a constitutive expression [26, 29]. In the hemolymph of
arthropods, the antimicrobial peptides occur in the mi-
cromolar range, whereas the concentration of some pep-
tides in the venom reach the millimolar range [79, 82, 96,
125]. 
For the honeybee, it could be shown that the sequential
processing of the melittin precursor by dipeptidyl-
aminopeptidases in a late step of the biosynthesis occurs
after the precursor has entered the venom sac. The chitin
wall of the venom sac prevents contact of melittin with
phospholipid bilayers and a damage of the venom gland
by its own components [132]. Antimicrobial- and cy-
tolytic-acting peptides seem to be constitutively present
in the venom glands, but great variations are also reported
for melittin [133] and the degranulating activity from the
venom of Parabuthus schlechterii [63], which is ex-
plained as a function of seasonal factors, food and the de-
velopment stage of the arthropods.
Why are these cytolytic peptides in venom?
So far, investigations of the cytolytic peptides presented
above have focused more on effects on different verte-
brate cells as well as on prokaryotic and eukaryotic mi-
croorganisms but have neglected arthropods, which rep-
resent the most probable target of these predators and
their cytolytic peptides. The venoms of scorpions, spiders
and aculeate hymenopterans contain a complex mixture
of different compounds with the aim of paralyzing and/or
killing a given prey item, but also to deter invertebrate
and vertebrate aggressors as quickly as possible. 
Prey catching is a dangerous act for a predator because
many arthropods that may become the prey of a scorpion,
spider or predacious wasp possess defense weapons
(chewing mouth parts or strong legs with thorns) that
could hurt the predator considerably. In the case of social
bees or ants, invertebrate or vertebrate predators could do
tremendous damage to their colony or nest. Therefore, the
evolution of arthropod venoms must have tended toward
fast-acting venom. Because the reasons for using venom
may be different, venom composed of different sub-
stances may be useful. These compounds focus on rapid
paralysis, fast death and/or short, sharp pain. Assuming
that venom composition is also liable to optimization
pressure, one would expect minimized concentrations of
single compounds, synergisms between compounds, and
highly effective substances. This may reduce energy costs
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for biosynthesis of the constitutively venomous sub-
stances as well as the danger of injury by prey.
Injection of venom into an invertebrate prey results in di-
rectly affecting the central nervous system, as concluded
for some solitary aculeate wasps [134] and the scorpion
Leiurus quinquestriatus [135]. In contrast, it is reported
that Philanthus stings the honeybee in the thorax gan-
glion region from where the venom is then distributed by
the hemolymph, causing peripheral muscle paralysis
[136]. Venom injection of spiders also occurs in the back
of a fly’s head and in the thorax, abdomen and femur
[137]. Frequently, venom injection by aculeate hy-
menopterans, spiders and scorpions takes place in the soft
parts of the thorax and is perhaps injected directly into the
skeletal muscles and/or hemolymph of arthropods, where
the diverse paralyzing and neurotoxic substances still
must pass several cellular barriers to reach their targets. 
Although the venoms of scorpions, spiders and hy-
menopterans are composed of different neurotoxic sub-
stances, they show parallels in the presence of different
enzymes and low-molecular-mass substances such as his-
tamine and potassium ions [24, 25, 54, 83, 138]. A first
well-known step in quickly reaching a cellular target is a
high hyaluronidase content, which is present in many hy-
menopteran [25], scorpion and spider venoms [24, 83,
139]. This enzyme acts as a spreading agent and hy-
drolyzes the macropolysaccharide polymers, hyaluronic
acid and chondroitin sulphate that constitute the bulk of
animal connective tissue [124]. A second widespread en-
zyme, phospholipase A2 and/or B, is also present in all
arthropod venoms except those of spiders. It catalyzes the
hydrolysis of lipids and achieves, in combination with
melittin, the breakdown of membrane structures [96]. 
The brain and the nervous system of insects are protected
from direct contact with the hemolymph by the he-
molymph-brain barrier [140]. The rather permeable acel-
lular neurolemma (containing glycoaminoglycans, nega-
tively charged papilin and arthrosides) [140–141] is fol-
lowed by the main barrier: the perineurium. Further, glial
cells and axons are embedded in the hyaluronic-acid-con-
taining extracellular matrix [141, 142].
Peripheral axons are encapsulated by glial cells [143] and
separated from the hemolymph, as well as the CNS and
muscles, by the basement membrane containing nega-
tively charged papilin, MDP-1, and arthrosides [144–
146]. At the neuromuscular endplate of insects, the axon
may lie in a groove formed in the surface of the muscle
fiber or completely engulfed by the muscle cells. Axons
that synapse on the muscle surface are normally capped
by a layer of glial cells comparable to the neuromuscular
endplate of vertebrates and are not freely accessible for
neurotoxins. On the other hand, it has also been shown for
insects that some axon terminals and those that penetrate
the muscle fibers are not ensheathed by Schwann cells
[147] and are therefore accessible for neurotoxins.
It is conceivable that the linear cytolytic peptides become
attracted by the negatively charged basement membranes,
resulting in an a-helical conformation that disturbs mem-
branes and influences cell excitability. Peptides such as
lycotoxin I cause the dissipation of ion and voltage gra-
dients across nerve membranes and block neuromuscu-
lar transmission in insect body wall muscles [79].
Mastoparan acts on G proteins [118]. Further, parabuto-
porin depolarizes rat dorsal ganglion cells [63], and ox-
iopinins disturb the membrane potential of insect cells up
to their lysis [80]. As mentioned above, melittin exhibits
both facilitation and inhibition of enzyme activities. Fur-
ther, the peptide associates spontaneously with the nega-
tively charged cardiolipin and ganglioside GM1, a sialic-
acid-containing glycosphingolipid present mainly in the
outer eukaroytic plasma membrane of nerve cells [102,
104]. No further information is available on the synergis-
tic effects of these peptides with other venom compounds
[80, 82, 125].
In favor of a dual role of the cytolytic peptides, they could
(i) facilitate venom activity as explained above and (ii) be
a part of the antimicrobial defense system inside the
venom glands, aimed at possible infectious microorgan-
isms from the ingestion of infected prey animals or infec-
tion of the venom glands during venom injection [59, 64,
66, 67, 79]. Further, it has been proposed that cytolytic
peptides could play a conserving role in paralyzed cater-
pillars, which many solitary wasps provide as nutrition
for their offspring [116]. There are also a number of other
suggestions as to the reason for cytolytic peptides in the
venom of arthropods: one author group [148] reported
that threatened Hadrurus scorpions spray venom against
aggressors; another group [67] observed that scorpions
clean their bodies with their own venom from ‘dirty and
possible saprophytic organisms’, and it was assumed that
ants use their venom as an aerosol to protect their brood
from microorganisms [125, 149]. Today it is difficult to
decide whether these are biologically relevant aspects.
They certainly require more detailed confirmation.
Conclusions
Despite their excellent antimicrobial activities, we have
to realize that antimicrobial and cytolytic peptides from
arthropod venom are at present not well suited for new
antibiotic drugs since many of them do not sufficiently
discriminate between microorganisms (pathogens) and
erythrocytes (eukaryotic cells). Up to now, numerous ef-
forts have attempted to elucidate the structural basis of
their broad cytolytic activity, but the underlying mecha-
nisms are still not well understood [150]. Meanwhile, the
antifungal peptide ETD-151 derived from an antifungal
peptide from insect hemolymph is a promising drug can-
didate that shows no signs of toxicity in animal models
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even in high concentrations [151]. The cytolytic peptides
presented here derive from only a few venomous arthro-
pod species. Most possess several cytolytic peptides, and
we can easily anticipate that among the more than 1 mil-
lion arthropod species (of which at least 20% have venom
glands), a much larger molecule variety must be ex-
pected. The hitherto isolated and characterized cytolytic
peptides from arthropod venom are therefore only the tip
of the iceberg. The more new structures we identify, the
better we can predict structural features that help us to re-
duce undesirable side effects on eukaryotic cells. So in
the long run, the possibility that cytolytic peptides may
yet provide new antimicrobial drugs should not be ex-
cluded.
Finally, the effective and broad activity of cytolytic pep-
tides can be a valuable instrument in enhancing, together
with arthropod neurotoxins, the insecticidal activity of
genetically modified insect-specific baculoviruses as
biopesticides [80, 152]. Incorporated into the genome of
genetically engineered anophelines, cytolytic peptides
could amplify the innate immune defense system in
achieving a malaria-resistant insect [59]. Since there are
many ecological problems that have to be solved when
following such an approach, I again believe that this op-
tion will work only in the long run.
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